Key result
Novel therapies for pulmonary hypertension expand significantly over two decades, driven by growing clinical interest.
Why the study?
Pulmonary hypertension has seen significant advances in understanding and novel therapies over the past two decades, warranting a comprehensive review.
Key points are not available for this paper at this time.
Design
Review article
Answers are grounded in this paper and cite their sources.
May inform evolving pulmonary hypertension management; leaves open optimal sequencing and long-term outcome data from prospective trials.
There are few areas in respiratory medicine in which a greater interest and understanding has led to more novel therapies over the past two decades than pulmonary hypertension. In addition, breakth...
No takes yet. Share an insight, caveat, or question.
Rubin et al. (2011) studied this question. Pulmonary hypertension has seen a significant expansion in novel therapies over the past two decades driven by greater clinical interest and understanding.
Synapse has enriched 10 related papers. Consider them for comparative context: